Extendicare (TSE:EXE – Get Free Report) was upgraded by Cormark to a “moderate buy” rating in a research note issued to investors on Wednesday,Zacks.com reports.
Other analysts have also recently issued reports about the company. TD Securities raised their price objective on Extendicare from C$9.50 to C$10.50 and gave the company a “hold” rating in a research report on Thursday, November 14th. BMO Capital Markets set a C$11.00 price target on Extendicare and gave the company a “market perform” rating in a research note on Thursday, January 30th. Finally, Royal Bank of Canada lifted their price objective on shares of Extendicare from C$9.50 to C$11.00 and gave the stock a “sector perform” rating in a research report on Thursday, November 28th. Three equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of C$10.25.
Check Out Our Latest Analysis on EXE
Extendicare Stock Up 2.1 %
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Featured Stories
- Five stocks we like better than Extendicare
- What Are Treasury Bonds?
- 3 Beauty Stocks Off to an Ugly Start—Can 1 Stage a Comeback?
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Fastenal : Growth Trends, Challenges & Key Investment Insights
- Stock Analyst Ratings and Canadian Analyst Ratings
- 2 Auto Stocks to Let Go and 1 Worth Buying for the Long Haul
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.